These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15778601)

  • 1. Opinions on risk factors and management of corneal graft rejection in the United kingdom.
    Koay PY; Lee WH; Figueiredo FC
    Cornea; 2005 Apr; 24(3):292-6. PubMed ID: 15778601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
    Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
    Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Australian practice in the prevention and management of corneal allograft rejection.
    Barker NH; Henderson TR; Ross CA; Coster DJ; Williams KA
    Clin Exp Ophthalmol; 2000 Oct; 28(5):357-60. PubMed ID: 11097282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of corneal graft rejection: current practice patterns (2004).
    Randleman JB; Stulting RD
    Cornea; 2006 Apr; 25(3):286-90. PubMed ID: 16633028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current practices in the prevention and treatment of corneal graft rejection.
    Rinne JR; Stulting RD
    Cornea; 1992 Jul; 11(4):326-8. PubMed ID: 1424653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience.
    Young AL; Rao SK; Cheng LL; Wong AK; Leung AT; Lam DS
    Eye (Lond); 2002 May; 16(3):304-8. PubMed ID: 12032722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cyclosporine in corneal transplantation.
    Ziaei M; Manzouri B
    Cornea; 2015 Jan; 34(1):110-5. PubMed ID: 25357076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
    Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
    J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus.
    Sy A; McLeod SD; Cohen EJ; Margolis TP; Mannis MJ; Lietman TM; Acharya NR
    Cornea; 2012 Jul; 31(7):786-90. PubMed ID: 22269677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection.
    Tabbara KF
    Int Ophthalmol; 2008 Jun; 28(3):223-32. PubMed ID: 17634865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
    Unal M; Yücel I
    Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
    Jhanji V; Agarwal T; Sharma N; Vajpayee RB
    Eye Contact Lens; 2010 Nov; 36(6):371-3. PubMed ID: 20935566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of corneal graft practice in the United Kingdom.
    Burdon MA; McDonnell P
    Eye (Lond); 1995; 9 ( Pt 6 Su)():6-12. PubMed ID: 8729012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with herpes simplex virus eye disease having cataract surgery in the United Kingdom.
    Sykakis E; Karim R; Parmar DN
    J Cataract Refract Surg; 2013 Aug; 39(8):1254-9. PubMed ID: 23889868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.
    Shimazaki J; Den S; Omoto M; Satake Y; Shimmura S; Tsubota K
    Am J Ophthalmol; 2011 Jul; 152(1):33-39.e1. PubMed ID: 21570054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
    Reis A; Reinhard T; Voiculescu A; Kutkuhn B; Godehardt E; Spelsberg H; Althaus C; Sundmacher R
    Br J Ophthalmol; 1999 Nov; 83(11):1268-71. PubMed ID: 10535855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%].
    Alalwani H; Omer Saleh B; Rocher N; Renard G; Bourges JL; Legeais JM
    J Fr Ophtalmol; 2010 Dec; 33(10):710-4. PubMed ID: 21093105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.